Developed and implemented drug utilization review, clinical practice guidelines, treatment algorithms, and educational intervention programs enabling pharmaceutical manufacturers to partner with their managed care customers.
Helped a major pharmaceutical company develop an integrated strategic plan for marketing in the managed care, federal, hospital, and long-term health care sectors.
Conducted a product reimbursement project for a medical device company that identified maximal reimbursement methods for hospital clients.
Assisted management in identifying and understanding changes in public and private health care policy, interpreting the likely business implications, and formulating appropriate responses.
Conducted a cost-effectiveness study comparing outcome, length of stay, and hospital charges among therapeutic alternatives (thrombolytic drugs and surgery) for treating peripheral arterial occlusion.
Assisted a company, through an interactive workshop, in understanding the implications and responding to the issues of therapeutic substitution and a potential National Pharmacy and Therapeutics Committee.
Identified and defined components contributing to rapidly escalating prescription expenses for the employer members of a health care coalition. Evaluation included analysis of trends, supply characteristics analysis, state-of-the-art review, analysis of potential methods to help control costs, and the financial implications of various alternatives to existing programs.
Developed an economic model for a medical device manufacturer to position a new medical device in a favorable manner for public and private payers.
